Last reviewed · How we verify
Curare
At a glance
| Generic name | Curare |
|---|---|
| Also known as | Succinylcholine |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Modality | Small molecule |
| Therapeutic area | Rare Disease |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of the Bilateral TAP Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study (PHASE4)
- Opioid-Free Anesthesia in Cardiac Surgery (PHASE3)
- Intraoperative Methadone for the Prevention of Postoperative Pain (PHASE3)
- Assessment of Transnasal Humidified Rapid-insufflation Ventilatory Exchange (THRIVE) for Maternal Pre-oxygenation (NA)
- Avoid With Locoregional Analgesia Persistant Postoperative Pain In Children (PHASE3)
- Hernia Repair Using the Totally ExtraPeritoneal (TEP) Laparoscopic Approach Without Curare and Without Orotracheal Intubation.
- Evaluation of Pain Levels by Quantitative Pupillometry During the Placement of Deep Venous Catheters in Sedated Patients in Intensive Care Unit (PUPICAT)
- Improving Awakening Prognostication After Non Anoxic Coma Using PET-MRI in Intensive Care Unit (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Curare CI brief — competitive landscape report
- Curare updates RSS · CI watch RSS
- Centre Hospitalier Universitaire, Amiens portfolio CI